Article
A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
23 Jun 2020
Abstract excerpt
Temozolomide (TMZ) is the first-line chemotherapy drug that has been used to treat glioma for over a decade, but the benefits are limited by half of the treated patients who acquired resistance. Studies have shown that glioma TMZ resistance is a complex process with multiple factors, which has not been fully elucidated. Ferroptosis, which is a new type of cell death discovered in recent years, has been reported...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
